Brind.

Supernus Pharmaceuticals' ONAPGO is facing competition from AbbVie's pump, while Cantor Fitzgerald makes inquiries into the market for Qelbree.

1 report, 0 independent Updated Jun 27

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Supernus Pharmaceuticals (United States)AbbVie Cantor Fitzgerald

Keep exploring

The entities involved

Supernus Pharmaceuticals (United States)
company in Rockville, United States

Nothing else this week.
AbbVie
pharmaceutical company
- MarketBeat's screener has identified a list of dividend stocks.Sun 22:22
- AbbVie's product portfolio was bolstered by the acquisition of Allergan, while Humira sales faced erosion due to patent loss and biosimilar competition.Sun 13:48
Cantor Fitzgerald
American financial services company
- SoundHound is listed on the Nasdaq stock exchange, and its CEO has outlined the company's acquisition strategy.Mon 04:01
- Analyst firm lowered price targets on Automatic Data Processing (ADP) stock on June 6, 2026.Sun 18:41

Related events

AbbVie and Cisco are noted as large-cap holdings in the market.Sep 23

Coverage

Newest first; wire copies grouped

Jun 27Unknown outlet